期刊文献+

钙蛋白酶及其抑制剂对心肌肥厚模型大鼠心肌肥厚作用的研究

Myocardial Hypertrophy Process in Rat Model of Myocardial Hypertrophy Mediated by Calpain and Its Inhibitor
下载PDF
导出
摘要 目的研究钙蛋白酶calpain及其抑制剂MDL28170与心肌肥厚的关系,探讨心肌肥厚可能的作用机制。方法50只280-350g成年雄性Wistar大鼠随机分为正常对照组(NC组,n=5)、假手术组(SO组,n=5)、手术组(AO组,n=20)、手术+治疗组(AO+T组,n=20)。对AO组及AO+T组大鼠施行腹主动脉缩窄术建立心肌肥厚大鼠模型。4周后行心脏彩超检查。AO+T组大鼠MDL28170治疗2周后再行心脏彩超检查。取心脏称重,计算心重指数。Westernblot检测心肌中calpainl、calpain2、caNA的表达。结果心脏彩超证实4周后AO组及AO+T组大鼠心肌肥厚模型建立成功。药物干预后,AO+T组大鼠心肌肥厚得到控制,进展延缓,与AO组相比差距明显(P〈0.05)。AO组、AO+T组大鼠心脏质量、心重指数较NC组和S0组增加,AO组增加更明显(均P〈0.05)。与NC组相比,calpainl、calpain2、CaNA表达量在其余3组均有增加;而AO+T组与AO组比较calpainl、calpain2、CaNA表达量降低(P〈0.05)。结论钙蛋白酶calpain与心肌肥厚关系密切,CaN途径是其作用机制之一;calpain抑制剂MDL28170对实验条件下的心肌肥厚具有明显阻遏作用。 Objective To investigate the relationship between calpain and myocardial hypearophy, and further explore the underlying mecha- nism. Methods A total of 50 adult male Wistar rats (280-350 g) were randomly divided into 4 groups : normal control group (NC, n = 5), sham operation group (SO, n = 5 ), abdominal aortic operation group (AO, n = 20), abdominal aortic operation plus treatment group (AO+T, n = 20). AO group and AO+T group received the surgery of abdominal aortic coaretation. After 4 weeks, rats of AO+T group were given MDL28170 for ther- apy for 2 weeks. Then echocardiography examination was performed. The heart mass and calculate the ratio of heart mass and body weight in each group were recorded. The expression of calpainl, calpain2 and CaN A of myocardial tissue were determined by Western blot. Results The myo- cardial hypertrophy model was successfully established in both AO and AO+T group 4 weeks after operation, as echocardiography indicated. After drug intervention, rats of AO+T group developed a much slower progress of myocardial hypertrophy and the progressing was under control, which showed a significant gap compared with AO group (P 〈 0.05 ). The heart mass and the heart mass index (HMI) were increased significantly in AO and AO+T group than the other two groups, especially in AO group which was more serious (P 〈 0.05). Compared with NC group, the expression level of calpainl, calpain2, and CaN A were increased in the other 3 groups, while AO+T group showed a reduced expression by contrast of AO group. The differences between these 2 groups were statistically significant (P 〈 0.05). Conclusion Calpain is closely related with myocardial hypertrophy, and CaN signaling pathway is one of the most important mechanisms ; calpain inhibitor MDL28170 has an obvious inhibition effect on myocardial hypearophy under the experimental conditions.
作者 冯瑞 赵玫
出处 《中国医科大学学报》 CAS CSCD 北大核心 2016年第9期769-772,共4页 Journal of China Medical University
基金 国家自然科学基金(81100161)
关键词 心肌肥厚 大鼠 钙蛋白酶 CALPAIN 抑制剂 MDL28170 信号通路 CaN myocardial hypertrophy rat calpain inhibitor MDL28170 signaling pathway CaN
  • 相关文献

参考文献11

  • 1MIZUKAMI K, YOKOSHIKI H, MITSUYAMA H, et al. Small-con- ductance Ca2+-activated K+ current is upregulated via the phosphory- lation of CaMK II in cardiac hypertrophy from spontaneously hyper- tensive rats [J]. Am J Physiol Heart Circ Physiol, 2015, 309 (6) : H 1066-H1074. DOI: 10.1152/ajpheart.00825.2014.
  • 2HORTON JS, BUCKLEY CL, ALVAREZ EM, et al. The calcium re- lease- activated calcium channel orail represents a crucial compo- nent in hypertrophic compensation and the development of dilated cardiomyopathy [J ]. Channels (Austin), 2014, 8 ( 1 ) : 35-43. DOI: 10.4161/chan.26581.
  • 3LUO X, HOJAYEV B, JIANG N, et al. STIM 1-dependent store-oper- ated Ca2+ entry is required for pathological cardiac hypertrophy [J]. J Mol Cell Cardiol, 2012, 52 (1) : 136- 147. DOI: 10.1016/j. yjmcc.2011.11.003.
  • 4MEI M, TANG F, LU M, et al. Astragaloside 1V attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation [J]. Environ Toxicol Pharmacol, 2015,40 (3) :764-773. DOI: 10.1016/j.etap.2015.09.007.
  • 5YE T, WANG Q, ZHANG Y, et al. Over-expression of calpastatin in- hibits calpain activation and attenuates post-infarction myocardial remodeling [J]. PLoS One,2015,10(3) : e0120178. DOI: 10.1371/ journal.pone.0120178.
  • 6KUDO-SAKAMOTO Y, AKAZAWA H, ITO K, et al. Calpain-depen- dent cleavage of N-cadherin is involved in the progression of post- myocardial infarction remodeling [J]. J Biol Chem, 2014,289 (28) : 19408-19419. DOI : 10.1074/jbc.M 114.567206.
  • 7PENNANEN C, PARRA V, MORALES PE, et al. Mitochondrial fis- sion is required for cardiomyocyte hypertrophy mediated by a Ca2+- calcineurin signaling pathway [J]. J Cell Sci, 2014,127 (12) : 2659- 2671. DOI : 10.1242/jcs. 139394.
  • 8GASPAR-PEREIRA S, FULLARD N, TOWNSEND PA, et al. The NF-κB subunit c-Rel stimulates cardiac hypertrophy and fibrosis [J]. Am J Pathol, 2012, 180 (3) : 929-939. DOI: 10.1016/j.aj- path.2011.11.007.
  • 9DOUILLARD A, GALBES O, BEGUE G, et al. Calpastatin overex- pression in the skeletal muscle of mice prevents clenbuterol- in- duced muscle hypertrophy and phenotypic shift [J]. Clin Exp Phar- macol Physiol, 2012, 39 (4) : 364- 372. DOI: 10.1111/j.1440 - 1681.2012.05677.x.
  • 10LI Y, MA J, ZHU H, et al. Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 dia- betes [J]. Diabetes, 2011,60 (11) : 2985-2994. DOI: 10.2337/ db10-1333.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部